Pharmspective launches go-to-market AI platform AccessAI™

Pharmspective launches go-to-market AI platform AccessAI™

A first-of-its-kind AI tool ready to replace outdated methods of secondary research and gaining knowledge about the market access landscape

street. Louis, November 8, 2023 /PRNewswire/ — Pharmspective LLC today announced the introduction of AccessAI™, the first artificial intelligence (AI) tool designed to simplify market access knowledge acquisition for the biopharmaceutical industry.

AccessAI™ (https://access-ai.net/) contains a foundation of over 12,000 references curated and vetted from hundreds of data sources (updated daily) that discuss commercial and government insurers, reimbursement, delivery channels, distribution, and payment models , Policy, access, and coverage dynamics affecting drug manufacturers. AccessAI™ combines AI technology with expert knowledge updated daily to provide on-demand research on market access challenges facing pharmaceutical decision makers.

“AccessAI™ provides a long-awaited solution to outdated, inefficient and less cost-effective secondary research methods in obtaining answers to important market access questions,” he said. Nicole Espinoza, Vice President of Knowledge Management. “Gaining market access knowledge is ideal for leveraging recent advances in artificial intelligence to deliver research faster and more accurately.”

AccessAI™ is available as a subscription-based, web-enabled portal that resembles the simple interfaces associated with standard AI platforms. To support AccessAI™, the company has enlisted a dedicated content management team to help customers maximize the value of the platform across Payer Insights teams, account management organizations, Payer Marketing groups, and Access Strategy units.

“AccessAI™ is a prime example of how AI-powered chatbots can be used for maximum efficiency.” Lori BluntContent Acquisition Manager. “By connecting the generative content power of AccessAI™ with reliable, high-quality market access data sources, we can produce exceptional market research in a fraction of the time and cost of traditional secondary research approaches.”

Healthcare companies can contact Pharmspective about AccessAI™ via email:

(email protected)

Media communications

Pharmspective It is a knowledge management company in the field of healthcare. Pharmspective Markets currently accessay™, A first-of-its-kind market access AI tool that answers questions about the market access and payment landscape across the healthcare ecosystem, Health PlanView™, a a novel Payer analytics platform that provides a multi-stakeholder cost perspective, And View Policy™, medical policy analyst for over 5,000 medical policies specializing in the field of pharmaceuticals. We simplify understanding the healthcare ecosystem through cutting-edge technologies that illustrate the evolving healthcare landscape and go beyond legacy approaches to understanding the payer landscape.

Source Pharmspective

    (tags for translation) farmspecif

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *